Month: May 2025

IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer

Written by Customer Service on May 23, 2025. Posted in Public Companies.

Data show continuous clinically significant improvement, with median 13-month and 3-month increases in overall and progression-free survival, respectively, in treatment group Women treated with IMNN-001 and standard of care chemotherapy plus PARP inhibitors achieved nearly 12-month increase in PFS compared to standard of care; median OS in IMNN-001 treatment arm not yet reached after more than five years Phase 2 OVATION 2 Study results also published in peer-reviewed journal Gynecologic Oncology LAWRENCEVILLE, N.J., May 23, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced new positive data from the Company’s Phase 2 OVATION 2 Study of IMNN-001, an investigational therapy for the treatment of advanced ovarian cancer. Results are...

FRO – Q1 2025 Presentation

Written by Customer Service on May 23, 2025. Posted in Public Companies.

Please find enclosed the presentation of Frontline plc´s first quarter 2025 results to be held on the webcast / conference call 23 May, 2025 at 15:00 CET. This information is subject to the disclosure requirements pursuant to section 5 – 12 of the Norwegian Securities Trading Act.AttachmentPresentation Q1 2025

Correction: Invesco Ltd: Form 8.3 – Adriatic Metals plc.; Opening Position disclosure

Written by Customer Service on May 23, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 CORRECTION: PUBLIC OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE *An amendment has been made to the reported holding figure in section 2 (a)* Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Invesco Ltd.(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Adriatic Metals plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of...

AGF Investments Announces May 2025 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure ETF

Written by Customer Service on May 23, 2025. Posted in Dividend Reports And Estimates.

TORONTO, May 23, 2025 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) (TSX:AGF.B) today announced the May 2025 cash distributions for AGF Enhanced U.S. Equity Income Fund*, AGF Total Return Bond Fund* and AGF Systematic Global Infrastructure ETF, which pay monthly distributions. Unitholders of record on May 30, 2025 will receive cash distributions payable on June 5, 2025. Details regarding the final “per unit” distribution amounts are as follows:ETF Ticker Exchange Cash Distribution Per Unit ($)AGF Enhanced U.S. Equity Income Fund* AENU Cboe Canada Inc. $0.129939AGF Total Return Bond Fund* ATRB Cboe Canada Inc. $0.092000AGF Systematic Global Infrastructure ETF QIF Cboe Canada Inc. $0.142740*AGF Enhanced U.S. Equity Income Fund and AGF Total Return Bond Fund are mutual funds with an ETF series option. Further...

Form 8.3 – [Craneware PLC]

Written by Customer Service on May 23, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Danske Bank A/S(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Craneware PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position...

Sol-Gel Reports First Quarter 2025 Results

Written by Customer Service on May 23, 2025. Posted in Earnings Releases And Operating Results.

NESS ZIONA, Israel, May 23, 2025 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March 31, 2025. Financial Results for the First Quarter Year Ended March 31st, 2025 Total revenue in the first quarter was $1 million compared to $0.5 million revenues for the same period in 2024. Research and development expenses were $8.8 million compared to $5.3 million in the same period in 2024. The increase of $3.5 million was primarily attributed to an increase of $3.6 million due to expenses associated with supplier-led manufacturing development to support future commercialization of SGT-610, an increase of $0.5 million related to the commercialization of EPSOLAY and TWYNEO in territories outside of the U.S., offset by a decrease...

LYB announces increase to quarterly dividend

Written by Customer Service on May 23, 2025. Posted in Dividend Reports And Estimates.

HOUSTON and LONDON, May 23, 2025 (GLOBE NEWSWIRE) — LyondellBasell (NYSE: LYB) today announced its board of directors has declared a quarterly dividend of $1.37 per share, representing a $0.03 per share increase over the company’s first quarter 2025 dividend. The dividend will be paid to shareholders on June 9, 2025, with an ex-dividend and record date of June 2, 2025. “LYB continues to reward shareholders with a strong and growing dividend in 2025, which will mark 15 consecutive years of dividend increases,” said CEO Peter Vanacker. “The growth of our dividend reaffirms confidence in our disciplined capital deployment, our value-driven strategy and our capability to navigate the cycle during these challenging times.” About LyondellBasell  We are LyondellBasell (NYSE: LYB) – a leader in the global chemical industry creating...

Form 8.5 (EPT/RI) – H & T Group

Written by Customer Service on May 23, 2025. Posted in Mergers And Acquisitions.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree H&T Group Plc(c) Name of the party to the offer with which exempt principal trader is connected: H&T Group Plc(d) Date dealing undertaken: 22 May 2025(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a) Purchases and salesClass...

Havila Kystruten AS: Invitation to Q1 2025 Earnings Call Presentation

Written by Customer Service on May 23, 2025. Posted in Public Companies.

Havila Kystruten AS will publish its Q1 2025 financial report on Tuesday, May 27, 2025. Bent Martini, CEO, and Aleksander Røynesdal, CFO, will present the results in an earnings call at 10:00 CET on Wednesday, May 28, 2025, followed by a Q&A session. The earnings call can be accessed through the following link: https://www.appairtime.com/event/34adb14b-3b85-492e-b6f9-5a5edb65e391 A recording will be available on the Company’s website. Contacts: Chief Executive Officer: Bent Martini, +47 905 99 650 Chief Financial Officer: Aleksander Røynesdal, +47 413 18 114 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Form 8.3 – [CRANEWARE PLC – 22 05 2025] – (CGWL)

Written by Customer Service on May 23, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CRANEWARE PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Month: May 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals